Shamburg News · 8-K filed Nov 12, 2026, 4:11 PM EST

MacroGenics Reports Third Quarter 2026 Financial Results and Pipeline Progress

MGNX · MACROGENICS INC

  • Earnings
  • Other event
  • Materiality: high

MacroGenics reported a total revenue of $18.7 million for the quarter ended September 30, 2026, down from $53.0 million a year earlier, and a net loss of $20.1 million, compared with net income of $16.8 million in the prior-year quarter. Basic and diluted net loss per share were $(0.32). Cash, cash equivalents and marketable securities were $287.7 million as of September 30, 2026, and the company stated that its cash runway guidance extends through 2028.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001125345-26-000074.

Written from the filing by Shamburg Markets. Figures are as reported by the company.